Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Are there any drugs that should not be taken during the trial?

While most medications are safe to take, some other cholesterol-lowering drugs, like evolocumab (Repatha®) and alirocumab (Praluent®), should not be taken at the same time because they target the same pathway as inclisiran.